Emerging proteomic technologies provide enormous and underutilized potential for brain cancer research
作者： Qiang Tian , Vineet Sangar , Nathan D. Price
关键词:
摘要: High-throughput technologies present immense opportunities to characterize brain cancer biology at a systems level. However, proteomic studies of cancers are still relatively scarce. Here we discuss the latest technologies, their application profiling and quantitation proteomes how expect these will be applied study in future. Mass spectrometry based proteomics with increased specificity, coverage throughput pervasive investigations brain. Generated data needs captured by curation databases, creative analysis strategies is needed provide meaningful insights into functions associated pathologies. Overall, applications earliest stages expanded use holds enormous potential improve our understanding
elsevier.com
sci-hub.se 参考文章(39)
Alja Videtic Paska, Petra Hudler, Aberrant methylation patterns in cancer: a clinical view. Biochemia Medica. ,vol. 25, pp. 161- 176 ,(2015) , 10.11613/BM.2015.017
Ivo A Hendriks, Rochelle C D’Souza, Jer-Gung Chang, Matthias Mann, Alfred CO Vertegaal, None, System-wide identification of wild-type SUMO-2 conjugation sites Nature Communications. ,vol. 6, pp. 7289- 7289 ,(2015) , 10.1038/NCOMMS8289
Nitya Nair, Henrik E Mei, Shih-Yu Chen, Matthew Hale, Garry P Nolan, Holden T Maecker, Mark Genovese, C Garrison Fathman, Chan C Whiting, Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy. Arthritis Research & Therapy. ,vol. 17, pp. 127- 127 ,(2015) , 10.1186/S13075-015-0644-Z
Janani Panneerselvam, Manish Shanker, Jiankang Jin, Cynthia D. Branch, Ranganayaki Muralidharan, Yan D. Zhao, Sunil Chada, Anupama Munshi, Rajagopal Ramesh, Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity Oncotarget. ,vol. 6, pp. 16271- 16286 ,(2015) , 10.18632/ONCOTARGET.3977
Rachel Yoon Kyung Chang, Naomi Etheridge, Amanda S. Nouwens, Peter R. Dodd, SWATH analysis of the synaptic proteome in Alzheimer's disease Neurochemistry International. ,vol. 87, pp. 1- 12 ,(2015) , 10.1016/J.NEUINT.2015.04.004
Yetrib Hathout, Edward Brody, Paula R. Clemens, Linda Cripe, Robert Kirk DeLisle, Pat Furlong, Heather Gordish-Dressman, Lauren Hache, Erik Henricson, Eric P. Hoffman, Yvonne Monique Kobayashi, Angela Lorts, Jean K. Mah, Craig McDonald, Bob Mehler, Sally Nelson, Malti Nikrad, Britta Singer, Fintan Steele, David Sterling, H. Lee Sweeney, Steve Williams, Larry Gold, Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy Proceedings of the National Academy of Sciences of the United States of America. ,vol. 112, pp. 7153- 7158 ,(2015) , 10.1073/PNAS.1507719112
Bryan D. Bryson, Forest M. White, Quantitative Profiling of Lysine Acetylation Reveals Dynamic Crosstalk between Receptor Tyrosine Kinases and Lysine Acetylation PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0126242
Akio Soeda, Akira Hara, Takahiro Kunisada, Shin-ichi Yoshimura, Toru Iwama, Deric M. Park, The Evidence of Glioblastoma Heterogeneity Scientific Reports. ,vol. 5, pp. 7979- 7979 ,(2015) , 10.1038/SREP07979
Bryan D. Bryson, Amanda M. Del Rosario, Jonathan S. Gootenberg, Michael B. Yaffe, Forest M. White, Engineered bromodomains to explore the acetylproteome PROTEOMICS. ,vol. 15, pp. 1470- 1475 ,(2015) , 10.1002/PMIC.201400401
Anniella Isgren, Joel Jakobsson, Erik Pålsson, Carl Johan Ekman, Anette G.M. Johansson, Carl Sellgren, Kaj Blennow, Henrik Zetterberg, Mikael Landén, Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment Brain Behavior and Immunity. ,vol. 43, pp. 198- 204 ,(2015) , 10.1016/J.BBI.2014.10.001